SKN7 Antibody

What is SKN7 and why is it an important target for antibody-based detection?

SKN7 is a yeast transcription factor that functions as a response regulator in oxidative stress response pathways. It belongs to the bacterial two-component response regulator family and plays a crucial role in controlling gene expression following oxidative stress. SKN7 regulates several genes including TRX2 (encoding thioredoxin) and genes encoding thioredoxin reductase . The protein is particularly important because it represents one of the few eukaryotic two-component signaling proteins that functions directly as a transcription factor . Antibodies against SKN7 are essential tools for studying its binding to promoters, protein-protein interactions, and cellular localization during stress responses. These antibodies enable researchers to track SKN7's activity across different cellular conditions and genetic backgrounds, providing insights into stress response mechanisms.

What experimental techniques commonly incorporate SKN7 antibodies?

SKN7 antibodies are utilized across multiple experimental approaches in yeast molecular biology:

• Electrophoretic Mobility Shift Assays (EMSAs): SKN7 antibodies are used in supershift assays to confirm the presence of SKN7 in DNA-protein complexes. Research has demonstrated that polyclonal antibodies against SKN7 can clearly supershift bands containing SKN7 bound to TRX2 promoter fragments .

• Chromatin Immunoprecipitation (ChIP): SKN7 antibodies help identify genomic binding sites and analyze the temporal dynamics of SKN7 recruitment to target promoters during oxidative stress.

• Western Blotting: For detecting SKN7 protein levels, modifications (such as phosphorylation), and comparing expression across different mutant strains.

• Immunofluorescence: To visualize the subcellular localization of SKN7 under various stress conditions.

• Co-immunoprecipitation: To investigate potential protein interactions, although some studies report difficulties in co-immunoprecipitating SKN7 with suspected interacting partners like Yap1 .

How do SKN7 antibodies help distinguish between SKN7's different functional roles?

SKN7 participates in multiple cellular processes including oxidative stress response, cell wall biosynthesis, and cell cycle regulation . SKN7 antibodies help researchers differentiate between these functions through:

• Promoter Binding Analysis: SKN7 antibodies in ChIP or EMSA experiments can identify which gene promoters SKN7 binds under specific conditions. For example, SKN7 binds directly to the TRX2 promoter during oxidative stress, which can be confirmed using anti-SKN7 antibodies in supershift assays .

• Mutant Studies: When combined with SKN7 mutants (such as D427N which affects the phosphorylable aspartate residue), antibodies can help determine which domains are essential for specific functions. Research shows that while the receiver domain phosphorylation is critical for cell wall and G1 cyclin gene regulation, it's dispensable for oxidative stress response gene regulation .

• Temporal Resolution: By analyzing cells at different time points following stress induction, antibodies can track SKN7's association with different promoters over time.

The ability to detect SKN7's presence at different promoters helps determine which genes require SKN7 phosphorylation (cell wall and G1 cyclin genes) versus those that don't (oxidative stress response genes) .

How can SKN7 antibodies be optimized for investigating SKN7-Yap1 cooperation on target promoters?

The cooperation between SKN7 and Yap1 on promoters like TRX2 presents a fascinating research area that requires specialized antibody applications:

Methodological Approach:

• Sequential Chromatin Immunoprecipitation (Re-ChIP): This technique uses:

  • First round: Anti-SKN7 antibody immunoprecipitation

  • Second round: Anti-Yap1 antibody immunoprecipitation of the first eluate

This approach can identify genomic regions where both proteins co-occupy DNA, which appears to be the case for the TRX2 promoter .

• Optimized EMSA Conditions: The search results indicate that EMSA analysis reveals a band containing both Yap1 and SKN7 proteins (band 1) and another containing only SKN7 (band 2) . To optimize these experiments:

  • Use antibodies against both proteins in supershift assays

  • Employ reciprocal competition assays with unlabeled probes

  • Compare binding patterns in wild-type, skn7Δ, yap1Δ, and double mutant extracts

• Proximity Ligation Assay (PLA): While direct co-immunoprecipitation of SKN7 and Yap1 has been unsuccessful , antibody-based PLA can detect proteins in close proximity (<40 nm) even when their interaction may be transient or DNA-dependent.

The research indicates an interesting complexity: although Yap1 and SKN7 both regulate TRX2 expression and appear to occupy the promoter simultaneously, direct protein interactions have been difficult to demonstrate through standard co-IP methods . This suggests their cooperation may require DNA binding or additional factors.

What approaches using SKN7 antibodies can distinguish between phosphorylated and non-phosphorylated forms?

Distinguishing between phosphorylation states of SKN7 is critical for understanding its dual regulatory roles, particularly as the D427N mutation (which prevents phosphorylation) affects some functions but not others .

Recommended Methodological Approach:

• Phospho-specific Antibodies:

  • Generate antibodies specifically recognizing phosphorylated Asp427

  • Compare signals between wild-type SKN7 and D427N mutant as validation control

  • Use in Western blots with samples exposed to different stressors to track phosphorylation dynamics

• Phos-tag™ SDS-PAGE:

  • Combine standard SKN7 antibodies with Phos-tag™ acrylamide gels

  • This creates mobility shifts for phosphorylated proteins without requiring phospho-specific antibodies

  • Compare migration patterns between wild-type SKN7 and the D427N mutant protein

• Mass Spectrometry Following Immunoprecipitation:

  • Use SKN7 antibodies to immunoprecipitate the protein

  • Analyze by mass spectrometry to identify phosphorylation sites

  • Compare phosphorylation profiles across different stress conditions

The experiments should include careful controls as demonstrated in the literature, where researchers validated that D427N mutation in SKN7 affects its ability to rescue temperature sensitivity in swi4Δ strains (cell cycle function) but does not affect hydrogen peroxide resistance (oxidative stress function) .

A data comparison table based on the research findings would look like this:

How can ChIP-seq with SKN7 antibodies be optimized to identify novel binding sites?

ChIP-seq with SKN7 antibodies requires careful optimization due to the complex binding patterns of SKN7 and its cooperation with other transcription factors.

Methodological Recommendations:

• Crosslinking Optimization:

  • Test different formaldehyde concentrations (1-3%) and times (10-30 minutes)

  • SKN7's interaction with DNA appears to involve cooperation with other factors, potentially requiring gentler crosslinking to preserve complexes

• Antibody Selection and Validation:

  • Validate antibody specificity using skn7Δ strains as negative controls

  • Test antibodies against epitope-tagged SKN7 versions (ensuring the tag doesn't disrupt function)

  • Verify antibody effectiveness through pilot ChIP-qPCR on known targets like the TRX2 promoter region containing the SKN7 binding site between the Yap1 binding site and TATA sequence

• Experimental Design Considerations:

  • Include time-course analysis following oxidative stress induction

  • Compare binding profiles between normal and stress conditions

  • Include parallel ChIP-seq for Yap1 to identify co-regulated genes

  • Incorporate data from strains expressing the D427N variant to distinguish phosphorylation-dependent binding events

• Bioinformatic Analysis Pipeline:

  • Search for sequences similar to identified SKN7 binding sites, such as the 23-nucleotide region in the TRX2 promoter

  • Include motif analysis for sequences with similarity to HSE (Heat Shock Element) motifs, given SKN7's homology to heat shock factor (HSF1)

  • Cross-reference with transcriptomic data from skn7Δ strains

The literature indicates SKN7 binds within a specific 23-nucleotide region in the TRX2 promoter, and mutation of CG to TA within this region reduced binding 20-fold . This information provides valuable positive controls for ChIP-seq optimization.

What are the critical controls required when using SKN7 antibodies in EMSA supershift assays?

EMSA supershift assays with SKN7 antibodies require rigorous controls to ensure result validity, particularly when investigating complex promoter interactions like those observed with the TRX2 gene .

Essential Controls:

• Genetic Background Controls:

  • Wild-type extracts

  • skn7Δ extracts

  • yap1Δ extracts (when studying cooperative binding)

  • skn7Δ yap1Δ double mutant extracts

  • Complemented strains (skn7Δ with SKN7 plasmid)

• Antibody Specificity Controls:

  • Preimmune serum at equivalent concentration to test non-specific binding

  • Antibody titration series to determine optimal concentration

  • Antibody pre-absorption with purified antigen to confirm specificity

• Binding Specificity Controls:

  • Competition with excess unlabeled probe

  • Competition with mutated probe versions

  • Use of truncated/mutated promoter fragments

• Protein-specific Controls:

  • Include SKN7 mutant protein extracts (e.g., D427N) to assess functional domain requirements

  • Test recombinant SKN7 protein if available

The search results demonstrate the value of these controls, showing how researchers distinguished between Skn7-dependent (band 2) and Skn7/Yap1-dependent (band 1) complexes through careful analysis of band patterns across different genetic backgrounds .

How should researchers validate the specificity of newly-developed SKN7 antibodies?

Comprehensive validation of SKN7 antibodies is crucial for reliable experimental outcomes.

Recommended Validation Protocol:

• Genetic Validation:

  • Western blot comparison of wild-type vs. skn7Δ extracts

  • Testing against strains expressing epitope-tagged SKN7 (if tag doesn't interfere with function)

  • Immunoblotting of extracts from strains with SKN7 overexpression

• Biochemical Validation:

  • Reactivity against recombinant SKN7 protein

  • Peptide competition assays using the immunizing peptide

  • Cross-reactivity assessment with related proteins, particularly those with homologous domains like HSF1

• Application-specific Validation:

  • For EMSAs: Ability to supershift known SKN7-DNA complexes

  • For ChIP: Enrichment of known SKN7 target sequences

  • For immunofluorescence: Absence of signal in skn7Δ cells

• Domain Specificity Testing:

  • Test against SKN7 truncation mutants to confirm epitope accessibility

  • Verify reactivity with phosphorylated vs. non-phosphorylated forms if using domain-specific antibodies

The literature demonstrates successful validation where anti-SKN7 antibodies specifically supershifted bands 1 and 2 in EMSAs, with preimmune serum showing no effect , confirming antibody specificity.

What methodological approaches can distinguish between SKN7's dual roles in stress response and cell wall regulation?

SKN7 has distinct roles in oxidative stress response versus cell wall/cell cycle regulation, with the latter requiring phosphorylation of the D427 residue . Antibody-based methods can help distinguish these functions.

Methodological Approaches:

• Comparative ChIP Analysis:

  • Use SKN7 antibodies for ChIP under different stress conditions

  • Compare promoter occupancy during oxidative stress vs. cell wall stress

  • Include the D427N mutant to identify phosphorylation-dependent binding events

• Phosphorylation-state Detection:

  • Use phospho-specific antibodies if available

  • Alternatively, immunoprecipitate SKN7 using standard antibodies followed by phosphorylation detection

  • Compare phosphorylation status across different stress conditions

• Temporal Analysis with Co-factor Detection:

  • Perform sequential ChIP (Re-ChIP) with antibodies against SKN7 and co-factors

  • For oxidative stress genes: SKN7 + Yap1

  • For cell wall genes: SKN7 + potential MCB/SCB-binding factors

• Binding Site Mutation Analysis:

  • Use EMSA with SKN7 antibodies to analyze binding to different target promoters

  • Compare binding to TRX2 promoter (oxidative stress) vs. cell wall gene promoters

  • Test binding to mutated versions of these promoters

The research findings indicate that SKN7's role in oxidative stress response doesn't require phosphorylation of D427, as the D427N mutant retains normal TRX2 induction and hydrogen peroxide resistance . In contrast, this same mutation disrupts SKN7's function in cell wall biosynthesis and G1 cyclin expression . This differential requirement provides a powerful tool for distinguishing between SKN7's dual roles.

How can researchers use SKN7 antibodies to investigate binding site specificity?

SKN7 binding site specificity is complex, with the protein recognizing sequences that may have limited similarity to heat shock elements (HSEs) and showing some context-dependent binding behaviors .

Methodological Approach:

• Systematic Promoter Dissection:

  • Create a series of overlapping EMSA probes as demonstrated with the TRX2 promoter

  • Test each fragment with wild-type and skn7Δ extracts

  • Use SKN7 antibodies in supershift assays to confirm specific binding

  • Map minimal binding regions through progressive truncations

• Mutational Analysis:

  • Introduce targeted mutations in candidate binding sites

  • Quantify binding affinity changes using EMSA with antibody confirmation

  • The research shows that mutation of CG to TA within the TRX2 23-nucleotide binding region reduced SKN7 binding 20-fold

• Cross-promoter Analysis:

  • Compare SKN7 binding sequences across multiple target genes

  • Analyze both oxidative stress-responsive genes and cell wall/cell cycle genes

  • Test competition between different promoter fragments in EMSAs

• Bioinformatic Approaches Combined with Experimental Validation:

  • Identify potential SKN7 binding motifs across the genome

  • Confirm with ChIP and EMSA using SKN7 antibodies

  • Correlate binding strength with sequence conservation

What are the optimal conditions for using SKN7 antibodies in co-immunoprecipitation experiments?

Despite challenges in detecting direct interactions between SKN7 and potential partners like Yap1 , optimized co-immunoprecipitation protocols may help identify SKN7 interaction partners.

Optimized Protocol:

• Crosslinking Considerations:

  • Test gentle crosslinking (0.1-0.5% formaldehyde) to capture transient interactions

  • Consider protein-protein crosslinkers like DSP (dithiobis[succinimidyl propionate])

  • For DNA-dependent interactions, include DNA digestion controls

• Extract Preparation:

  • Test multiple lysis buffers with varying salt concentrations (150-500 mM)

  • Include phosphatase inhibitors to preserve phosphorylation-dependent interactions

  • Consider nuclease treatment to distinguish DNA-mediated from direct interactions

• Immunoprecipitation Conditions:

  • Compare different antibody immobilization methods (protein A/G, direct coupling)

  • Test both N-terminal and C-terminal antibodies, as epitope accessibility may vary

  • Include gentle elution methods to preserve complex integrity

• Controls and Validation:

  • Use skn7Δ extracts as negative controls

  • Include non-specific IgG controls

  • Test reciprocal immunoprecipitation with antibodies against suspected partners

  • Confirm functional relevance through genetic studies (e.g., double mutant analysis)

While co-immunoprecipitation of SKN7 with Yap1 has been unsuccessful despite evidence of functional cooperation , the EMSAs showing a band containing both proteins suggest their interaction may be DNA-dependent or highly context-specific . This highlights the importance of including DNA in binding reactions and possibly testing conditions that preserve native chromatin structure.

How can SKN7 antibodies help investigate the relationship between SKN7 and heat shock response?

The high homology between SKN7's DNA-binding domain and that of heat shock factor (HSF1) suggests a potential functional relationship, which can be investigated using antibody-based approaches.

Experimental Strategy:

• Comparative ChIP Analysis:

  • Perform parallel ChIP experiments with antibodies against SKN7 and HSF1

  • Compare binding profiles under heat shock vs. oxidative stress

  • Identify genomic regions bound by both factors

• Sequential ChIP (Re-ChIP):

  • First round: Anti-SKN7 antibody

  • Second round: Anti-HSF1 antibody

  • This identifies loci where both proteins co-occupy the same genomic regions

• EMSAs with Supershift Analysis:

  • Test binding of SKN7 to HSE elements from heat shock genes

  • The research shows SKN7 can specifically bind to the HSE2 element from the SSA1 promoter

  • Use antibodies against both SKN7 and HSF1 in supershift assays

• Combined Genetic and Biochemical Approach:

  • Compare SKN7 binding in wild-type vs. HSF1 mutant backgrounds

  • Test temperature-sensitive hsf1 mutants alongside skn7Δ strains

  • Use SKN7 antibodies to track protein levels and binding during heat shock

Research has demonstrated that skn7Δ cells show approximately 10-fold increased sensitivity to acute heat stress (51°C), suggesting SKN7 contributes to heat tolerance . Additionally, evidence indicates that "Skn7 and Hsf1 cooperate to achieve maximal induction of heat shock genes in response specifically to oxidative stress" . Antibody-based approaches can help elucidate the mechanisms behind this cooperation.

How might developing monoclonal antibodies against specific SKN7 domains advance research?

Current research has primarily utilized polyclonal antibodies against SKN7 , but developing domain-specific monoclonal antibodies could open new research avenues.

Potential Applications:

• Phosphorylation-State Specific Antibodies:

  • Develop antibodies specifically recognizing phosphorylated D427

  • Enable direct tracking of phosphorylation status across different conditions

  • Help resolve the question of when SKN7 is phosphorylated during normal growth vs. stress

• Domain-Specific Functional Analysis:

  • DNA-binding domain-specific antibodies could potentially block binding without affecting protein-protein interactions

  • Receiver domain-specific antibodies might distinguish between active and inactive conformations

  • Use in ChIP to determine which domains are accessible in different promoter contexts

• Epitope Mapping of Protein-Protein Interfaces:

  • Series of monoclonals recognizing different epitopes could be used to map interaction surfaces

  • Competition assays could reveal which epitopes become masked during complex formation

  • Help identify the regions involved in potential SKN7-Yap1 interactions

• Conformational Antibodies:

  • Develop antibodies recognizing specific structural conformations of SKN7

  • Could potentially distinguish between DNA-bound and unbound states

  • Might reveal condition-specific conformational changes

The development of such specialized antibodies would build upon current research showing that SKN7 regulates distinct sets of genes through different mechanisms , potentially enabling researchers to track these different functional states in real-time.

What are the key considerations for developing ChIP-exo or ChIP-nexus protocols with SKN7 antibodies?

ChIP-exo and ChIP-nexus offer higher resolution mapping of transcription factor binding sites than standard ChIP-seq, which could be valuable for precisely defining SKN7 binding motifs.

Protocol Development Considerations:

• Antibody Suitability Assessment:

  • Test antibody performance in standard ChIP before advancing to ChIP-exo

  • Verify epitope accessibility when SKN7 is bound to DNA

  • Consider using epitope-tagged SKN7 with well-characterized tag antibodies as an alternative

• Crosslinking Optimization:

  • The cooperative binding of SKN7 with other factors like Yap1 requires careful optimization

  • Test different formaldehyde concentrations and times

  • Consider dual crosslinking approaches (formaldehyde + protein-specific crosslinkers)

• Exonuclease Digestion Parameters:

  • Optimize lambda exonuclease concentration and digestion time

  • Include known SKN7 binding sites (such as the TRX2 promoter ) as positive controls

  • Monitor digestion efficiency through qPCR of protected regions

• Data Analysis Considerations:

  • Compare binding motifs between oxidative stress-responsive genes and cell wall genes

  • Look for co-occurring motifs that might indicate cooperative binding

  • Integrate with transcriptomic data from SKN7 mutant strains

Higher resolution mapping could help resolve the precise nature of the SKN7 binding site, which has been characterized as having "limited homology to an HSE element" and "some limited homology to an SCB element" , potentially clarifying the exact sequence requirements for SKN7 binding.

How can quantitative approaches with SKN7 antibodies improve understanding of stress response dynamics?

Quantitative applications of SKN7 antibodies can provide insights into the dynamics of stress response regulation.

Methodological Approaches:

• Quantitative ChIP (qChIP):

  • Use SKN7 antibodies for ChIP followed by qPCR of target promoters

  • Create time-course profiles of SKN7 binding following stress induction

  • Compare binding kinetics across different stress conditions (oxidative, heat, cell wall)

  • Correlate with mRNA induction profiles of target genes

• Live-Cell Imaging with Antibody-Based Biosensors:

  • Develop intrabodies (intracellular antibodies) against SKN7

  • Couple with fluorescent reporters to track SKN7 localization and activity in real-time

  • Monitor dynamics of nuclear translocation during stress responses

• Absolute Quantification of SKN7 Levels:

  • Use purified recombinant SKN7 as a standard

  • Develop quantitative Western blot protocols with SKN7 antibodies

  • Measure absolute protein levels across different genetic backgrounds and conditions

• Proximity Ligation Assays:

  • Quantify interactions between SKN7 and partner proteins

  • Track formation and dissolution of complexes during stress response

  • Create spatial maps of interaction dynamics

The research indicates that SKN7 cooperates with Yap1 to induce transcription in response to oxidative stress , but the temporal dynamics of this cooperation remain unclear. Quantitative approaches could reveal whether these factors act simultaneously or sequentially, providing insights into the coordination of stress response pathways.